BLACK DIAMOND THERAPEUTICS, INC. Assets, Fair Value Disclosure
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Assets, Fair Value Disclosure of $109.43 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-05
- 2026-06-30: Assets, Fair Value Disclosure $109.43M.
- 2026-03-31: Assets, Fair Value Disclosure $117.18M.
- 2025-12-31: Assets, Fair Value Disclosure $127.57M.
- 2024-12-31: Assets, Fair Value Disclosure $97.48M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $109.43M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $117.18M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $127.57M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $97.48M 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |